Inventor
SONG COLETTE
DE213 patents
Patents
50 patentsUS10071148B2Sep 11, 2018
Immunotherapy against several tumors, such as lung cancer, including NSCLC
IMMATICS BIOTECHNOLOGIES GMBH198 citations99
US9943579B2Apr 17, 2018
Immunotherapy against several tumors, such as lung cancer, including NSCLC
IMMATICS BIOTECHNOLOGIES GMBH131 citations99
US10836806B2Nov 17, 2020
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH27 citations98
US11890334B2Feb 6, 2024
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH8 citations94
US11759507B2Sep 19, 2023
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH9 citations94
US11618774B2Apr 4, 2023
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations94
US11607446B2Mar 21, 2023
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11529400B1Dec 20, 2022
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11529401B2Dec 20, 2022
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11524059B2Dec 13, 2022
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US11414470B2Aug 16, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations94
US11407798B2Aug 9, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations94
US11370817B2Jun 28, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH6 citations94
US11324812B2May 10, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH11 citations94
US11279741B2Mar 22, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH7 citations94
US10946064B2Mar 16, 2021
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH15 citations94
US10925948B2Feb 23, 2021
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH12 citations94
US10898560B2Jan 26, 2021
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH11 citations94
US10898559B2Jan 26, 2021
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH11 citations94
US10662233B2May 26, 2020
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH11 citations94
US10577402B2Mar 3, 2020
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH12 citations94
US10550167B2Feb 4, 2020
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH12 citations94
US10526389B2Jan 7, 2020
Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH14 citations94
US10314896B2Jun 11, 2019
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH15 citations94
US10179165B2Jan 15, 2019
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH17 citations94
US10098938B2Oct 16, 2018
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH17 citations94
US10058598B2Aug 28, 2018
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH17 citations94
US11498948B2Nov 15, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations93
US11479589B2Oct 25, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations93
US11352401B1Jun 7, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations93
US11292821B2Apr 5, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH5 citations93
US11279740B2Mar 22, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH4 citations93
US11261224B2Mar 1, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH5 citations93
US11071773B2Jul 27, 2021
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH8 citations93
US11027002B2Jun 8, 2021
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH8 citations93
US10479818B2Nov 19, 2019
Immunotherapy against several tumors, such as lung cancer, including NSCLC
IMMATICS BIOTECHNOLOGIES GMBH7 citations93
US10323065B1Jun 18, 2019
Immunotherapy against several tumors, such as lung cancer, including NSCLC
IMMATICS BIOTECHNOLOGIES GMBH10 citations93
US10316063B1Jun 11, 2019
Immunotherapy against several tumors, such as lung cancer, including NSCLC
IMMATICS BIOTECHNOLOGIES GMBH11 citations93
US10160786B1Dec 25, 2018
Immunotherapy against several tumors, such as lung cancer, including NSCLC
IMMATICS BIOTECHNOLOGIES GMBH12 citations93
US10143730B2Dec 4, 2018
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH8 citations93
US10117917B2Nov 6, 2018
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH7 citations93
US10098937B2Oct 16, 2018
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH8 citations93
US10004792B2Jun 26, 2018
Peptides and combination of peptides for use in immunotherapy against various cancers
IMMATICS BIOTECHNOLOGIES GMBH8 citations93
US11890333B2Feb 6, 2024
Personalized immunotherapy against several neuronal and brain tumors
IMMATICS BIOTECHNOLOGIES GMBH6 citations86
US12005105B2Jun 11, 2024
Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11459366B2Oct 4, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH1 citations84
US11459365B2Oct 4, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11427622B2Aug 30, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11414473B2Aug 16, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations84
US11414471B2Aug 16, 2022
Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
IMMATICS BIOTECHNOLOGIES GMBH2 citations84
Showing the top 50 of 213 patents by PatentIndex Score.